Explore how oxytocin influences social behavior, anxiety, and autism and its therapeutic potential in treating psychiatric ...

DENVER, Dec. 16, 2024 /PRNewswire/ -- Family Care Center has published promising new research on a groundbreaking treatment for patients with anxiety and major depressive disorder (MDD).

A new study explores whether cannabidiol (CBD), a component of marijuana, can reduce anxiety levels, specifically among patients with advanced breast cancer before a scan assessing tumor burden.

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects ...

What are the treatment options for anxiety? All patients need to be educated about ... disorder that is still common in people 50 years or older. It is neither possible nor desirable to eliminate ...

A study published in JAMA Network Open found that cannabidiol (CBD) may alleviate anxiety in women with advanced breast ...

Over 230,000 bottles of the antidepressant duloxetine (Cymbalta) have been recalled due to the presence of a potential ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

New phase 2 data on the treatment of older patients with secondary or high-risk acute myeloid leukemia (AML) may help to clarify which patients are most likely to benefit from therapy with CPX-351.

Depression, anxiety and other psychiatric ... Mental illness can be deadly for cancer patients because it often undermines their ability to follow through with treatment and adopt healthy habits ...